-
The Role of The Xihuang Pill in Inhibiting Triple-Negative Breast Cancer Through Immunogenic Cell Death
05 Sep 2025 13:47 GMT
… breast cancer, mechanism, immunogenic cell death
Background
In breast cancer patients, triple-negative breast cancer … ICD inducers. After doxorubicin chemotherapy for breast cancer, the transcription … microenvironment of 4t1 breast tumor-bearing mice by PI3K …
-
Phthalates in everyday products may fuel breast cancer
05 Sep 2025 12:57 GMT
… Medicine.
“As a breast tumor progresses through the stages … known to drive many breast cancers, phthalates can disrupt … drugs such as paclitaxel, doxorubicin, and tamoxifen.
Disrupt … type of breast cancer (estrogen receptor (ER)–positive breast cancer).
In …
-
Chemotherapy Confers No Survival Benefit in Older Breast Cancer Population
30 Aug 2025 19:38 GMT
… ER)–positive HER2-negative breast cancer vs hormonotherapy alone, … survival (DFS) or breast cancer-specific survival.
“In … ;m2 of doxorubicin, non-pegylated liposomal doxorubicin 60 mg… any second invasive cancer, breast cancer-specific survival, and safety …
-
Determination of 5-Fluorouracil in Dried Blood Spots for Therapeutic Drug Monitoring and Adverse Event Assessment in Breast Cancer Patients
29 Aug 2025 09:00 GMT
… commonly used to treat breast cancer, colorectal cancer, stomach … drug concentrations in breast cancer patients undergoing 5 … concurrently, such as doxorubicin and cyclophosphamide in … of capecitabine in metastatic breast cancer: confused, clarified or …
-
Patritumab Deruxtecan Enters Phase 3 for Metastatic HR+ Breast Cancer
27 Aug 2025 23:24 GMT
… nab-paclitaxel, capecitabine, liposomal doxorubicin, or trastuzumab deruxtecan (T-DXd … and triple-negative metastatic breast cancers,the ORR with patritumab deruxtecan … Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy …
-
Researchers Build Real-World External Control Arm to Accelerate HER2+ Breast Cancer Drug Development
26 Aug 2025 22:28 GMT
… development pipeline for HER2-positive breast cancer in particular, according to … doxorubicin in patients with HER2-positive locally advanced or metastatic breast cancer … 2 positive (HER2+) metastatic breast cancer. ClinicalTrials.gov. Updated January …
-
Paulus on Research With a Real-World External Control Arm in HER2+ Breast Cancer
26 Aug 2025 01:18 GMT
… liposomal doxorubicin in patients with HER2-positive locally advanced or metastatic breast cancer …
-
Application of Metal-Organic Frameworks Nanoparticles in the Diagnosis and Treatment of Breast Cancer
21 Aug 2025 21:58 GMT
… precision.
MOFs in Breast Cancer
Breast cancer is the most … in Breast Cancer Diagnosis and Treatments
For Breast Cancer Treatment … complementary modalities for breast cancer treatment.
For synergistic … targeted delivery of doxorubicin to breast cancer cells. ACS …
-
Jordanian researchers patent new compounds to treat breast cancer
20 Aug 2025 20:07 GMT
… the Hashemite University have identified doxorubicin and thymoquinone hybridized compounds with … useful for the treatment of breast cancer.
BioWorld Science Cancer Patents
-
Paulus on Leveraging Real-World Control Arms in Future HER2+ Breast Cancer Trials
13 Aug 2025 03:50 GMT
… liposomal doxorubicin in patients with HER2-positive locally advanced or metastatic breast cancer …
About
© 1995-2025